Immunosuppression is associated with loss of airway microbiome resilience in severe COVID-19.
8 affiliations
- 1Systems Genomics Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
- 2Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA.
- 3Department of Medicine, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA.
- 4Gutz Technologies, Corvina, CA, USA.
- 5Division of Pulmonary and Critical Care Medicine, VA New York Harbor Healthcare System, New York, NY, USA.
- 6Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA.
- 7Laura and Isaac Perlmutter Cancer Center, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA.
- 8Systems Genomics Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. [email protected].
Abstract
Background
The role of the lower airway microbiome in COVID-19-associated mortality remains poorly understood despite evidence implicating secondary pathogens and non-airway commensals. The influence of prior immunosuppression on the lower airway microbiome and its contribution to mortality in mechanically ventilated patients has been largely unexplored. Given that host-microbiome interactions are dynamic, we assessed longitudinal patterns in the respiratory microbiome associated with mortality and immunosuppression status.Results
We conducted longitudinal forecasting, differential abundance, and comparative network analyses of metatranscriptomic data from 604 upper and lower airway samples collected from 243 mechanically ventilated COVID-19 patients to profile key microbial factors associated with immunosuppression and clinical outcome. SARS-CoV-2 was enriched over time in immunosuppressed patients and in both immunosuppressed and immunocompetent patients who died, highlighting the need for aggressive viral infection control early in the disease course. Using longitudinal forecasting and differential abundance analyses, we observed a progressive increase in opportunistic pathogens, such as Staphylococcus aureus and Escherichia coli, among the taxa most predictive of mortality. Concurrently, immunosuppressed individuals exhibited a significant decrease in typical airway commensals alongside a restructuring and marked destabilization of the microbial community compared with their immunocompetent counterparts.Conclusions
These findings indicate that loss of airway microbiome stability in immunosuppressed patients constitutes an independent factor contributing to increased susceptibility to opportunistic pathogens and poor clinical outcomes. Video Abstract.
Related
- Re-Du-Ning Alleviates Airway-Intestinal Inflammation of COPD Rats by Regulating Glycerophospholipid Metabolism and Modulating Gut Microbiome
- Complex reoperative tracheobronchoplasty for persistent, severe excessive central airway collapse with mesh erosion
- Relapsing Polychondritis With Severe Airway Involvement Mimicking Refractory Asthma: A Diagnostic Challenge
- Severe Intraoperative Airway Leak Revealing Undiagnosed Mounier‐Kuhn Syndrome in an Elderly Patient
- Double‐lumen tube insertion and one‐lung ventilation in Coffin–Siris syndrome: navigating airway challenges in severe scoliosis surgery*
BibTeX
@article{chung2026immunosuppression,
title = {{Immunosuppression is associated with loss of airway microbiome resilience in severe COVID-19.}},
author = {Matthew Chung and Clea R Barnett and Lars Hunger and Imran Sulaiman and Benjamin G Wu and Yonghua Li and Jun-Chieh J Tsay and Shari B Brosnahan and Cecilia J Chung and Luis Angel and Gregg J Silverman and James T Morton and Leopoldo N Segal and Elodie Ghedin},
journal = {Microbiome},
year = {2026},
month = jul,
doi = {10.1186/s40168-026-02462-1},
url = {https://europepmc.org/article/MED/42897671},
note = {CC BY},
}
RIS
TY - JOUR
TI - Immunosuppression is associated with loss of airway microbiome resilience in severe COVID-19.
AU - Matthew Chung
AU - Clea R Barnett
AU - Lars Hunger
AU - Imran Sulaiman
AU - Benjamin G Wu
AU - Yonghua Li
AU - Jun-Chieh J Tsay
AU - Shari B Brosnahan
AU - Cecilia J Chung
AU - Luis Angel
AU - Gregg J Silverman
AU - James T Morton
AU - Leopoldo N Segal
AU - Elodie Ghedin
PY - 2026
DA - 2026/07/01
JO - Microbiome
DO - 10.1186/s40168-026-02462-1
UR - https://europepmc.org/article/MED/42897671
AB - Background The role of the lower airway microbiome in COVID-19-associated mortality remains poorly understood despite evidence implicating secondary pathogens and non-airway commensals. The influence of prior immunosuppression on the lower airway microbiome and its contribution to mortality in mechanically ventilated patients has been largely unexplored. Given that host-microbiome interactions are dynamic, we assessed longitudinal patterns in the respiratory microbiome associated with mortality and immunosuppression status.Results We conducted longitudinal forecasting, differential abundance, and comparative network analyses of metatranscriptomic data from 604 upper and lower airway samples collected from 243 mechanically ventilated COVID-19 patients to profile key microbial factors associated with immunosuppression and clinical outcome. SARS-CoV-2 was enriched over time in immunosuppressed patients and in both immunosuppressed and immunocompetent patients who died, highlighting the need for aggressive viral infection control early in the disease course. Using longitudinal forecasting and differential abundance analyses, we observed a progressive increase in opportunistic pathogens, such as Staphylococcus aureus and Escherichia coli, among the taxa most predictive of mortality. Concurrently, immunosuppressed individuals exhibited a significant decrease in typical airway commensals alongside a restructuring and marked destabilization of the microbial community compared with their immunocompetent counterparts.Conclusions These findings indicate that loss of airway microbiome stability in immunosuppressed patients constitutes an independent factor contributing to increased susceptibility to opportunistic pathogens and poor clinical outcomes. Video Abstract.
SN - 2049-2618
ER -